×

Transforming the Management

of Dermatologic Cancers

Enabling More Accurate Treatment Plan Decisions With Our Line of
Gene Expression Profile (GEP) Tests

CUTANEOUS MELANOMA

PROGNOSTIC

Predicting Individual Risk of Recurrence or Metastasis in Stage I, II and III Melanoma

DIAGNOSTIC

Highly Accurate and Objective Tests Characterizing Difficult-to-Diagnose Melanocytic Lesions

SQUAMOUS CELL
CARCINOMA

PROGNOSTIC

Better Identifies Risk of Metastasis in Patients With One or More Risk Factors

UVEAL
MELANOMA

PROGNOSTIC

The Standard of Care for Evaluating Metastatic Risk in Uveal Melanoma

Scroll to Top